Table 1
Functional analysis of single nucleotide polymorphisms (SNPs) by SIFT, PROVEAN, PolyPhen-2 and SNAP2 servers, showing 31 deleterious SNPs.
| dbSNP rs#* | Sub* | Sift prediction | Sift score | Provean prediction | PROVEAN score | Polyphen2 prediction | Polyphen2 score | Snap2 prediction | Snap2 Score |
|---|---|---|---|---|---|---|---|---|---|
| rs28942098 | M1I | afect | 0 | Deleterious | -2.586 | probably damaging | 0.999 | effect | 41 |
| rs1296841626 | L5F | afect | 0 | Deleterious | 2.676 | probably damaging | 1 | efect | 43 |
| rs770544416 | S6G | afect | 0 | Deleterious | -2.539 | possibly damaging | 0.567 | efect | 8 |
| rs1054465259 | G28A | afect | 0 | Deleterious | -3.745 | possibly damaging | 0.816 | efect | 47 |
| rs777541949 | T38S | afect | 0 | Deleterious | -2.785 | probably damaging | 1 | efect | 49 |
| rs1019931450 | Y40C | afect | 0 | Deleterious | -5.114 | probably damaging | 1 | efect | 56 |
| rs200806263 | G49C | afect | 0 | Deleterious | -5.363 | probably damaging | 1 | efect | 14 |
| rs1454615241 | T56I | afect | 0 | Deleterious | -4.102 | probably damaging | 1 | efect | 48 |
| rs1060500015 | L63P | afect | 0 | Deleterious | -4.277 | probably damaging | 1 | efect | 25 |
| rs121434264 | L64P | afect | 0 | Deleterious | -4.435 | probably damaging | 0.999 | efect | 60 |
| rs778467088 | D90H | afect | 0 | Deleterious | -5.36 | probably damaging | 1 | efect | 17 |
| rs1186176634 | S174P | afect | 0 | Deleterious | -2.64 | probably damaging | 1 | efect | 23 |
| rs770439843 | R222G | afect | 0 | Deleterious | -3.272 | possibly damaging | 0.955 | efect | 49 |
| rs776394390 | D223G | afect | 0 | Deleterious | -3.71 | probably damaging | 0.994 | efect | 25 |
| rs1330160847 | I224T | afect | 0 | Deleterious | -3.072 | probably damaging | 0.991 | efect | 25 |
| rs1060500022 | W231R | afect | 0 | Deleterious | -7.888 | probably damaging | 0.996 | efect | 64 |
| rs1452051467 | R234Q | afect | 0 | Deleterious | -3.063 | probably damaging | 1 | efect | 72 |
| rs973863694 | I249T | afect | 0 | Deleterious | -3.648 | probably damaging | 0.999 | efect | 33 |
| rs878855091 | R263C | afect | 0 | Deleterious | -3.402 | probably damaging | 1 | efect | 17 |
| rs1244272523 | R330W | afect | 0 | Deleterious | -3.789 | probably damaging | 0.996 | efect | 56 |
| rs770734388 | P360S | afect | 0 | Deleterious | -6.86 | probably damaging | 1 | efect | 59 |
| rs769288212 | P365L | afect | 0.04 | Deleterious | -8.661 | probably damaging | 1 | efect | 75 |
| rs113200235 | A367V | afect | 0.05 | Deleterious | -3.178 | probably damaging | 0.996 | efect | 66 |
| rs866465727 | V387A | afect | 0 | Deleterious | -3.326 | possibly damaging | 0.656 | efect | 48 |
| rs866793539 | G396C | afect | 0.02 | Deleterious | -7.128 | probably damaging | 1 | efect | 25 |
| rs754454928 | R441C | afect | 0 | Deleterious | -7.186 | probably damaging | 1 | efect | 58 |
| rs778432682 | R441H | afect | 0 | Deleterious | -4.441 | probably damaging | 1 | efect | 64 |
| rs1225502334 | R484C | afect | 0.05 | Deleterious | -3.972 | probably damaging | 0.994 | efect | 32 |
| rs1292596060 | R504S | afect | 0 | Deleterious | -5.296 | probably damaging | 1 | efect | 74 |
| rs759222387 | R504H | afect | 0 | Deleterious | -4.43 | probably damaging | 1 | efect | 73 |
| rs1060500011 | R513W | afect | 0.04 | Deleterious | -3.834 | probably damaging | 0.977 | efect | 59 |
[i] dbSNP rs*: is a locus accession for a variant type assigned by dbSNP, Sub*: substitution
Table 2
Functional analysis of single nucleotide polymorphisms (SNPs) by SNPs&GO, PHD and PMUT servers, showing eleven pathogenic SNPs.
| dbSNP rs#* | Sub* | SNPandGO Prediction | RI* | snp and go score | PHD Prediction | RI | PHD probability | PMut prediction | PMut score |
|---|---|---|---|---|---|---|---|---|---|
| rs200806263 | G49C | Disease | 7 | 0.829 | Disease | 8 | 0.893 | Disease | 0.54 (80%) |
| rs1060500015 | L63P | Disease | 3 | 0.657 | Disease | 7 | 0.861 | Disease | 0.68 (85%) |
| rs121434264 | L64P | Disease | 5 | 0.729 | Disease | 8 | 0.875 | Disease | 0.75 (87%) |
| rs778467088 | D90H | Disease | 4 | 0.708 | Disease | 7 | 0.867 | Disease | 0.70 (86%) |
| rs770439843 | R222G | Disease | 1 | 0.553 | Disease | 6 | 0.782 | Disease | 0.53 (80%) |
| rs1060500022 | W231R | Disease | 1 | 0.544 | Disease | 1 | 0.56 | Disease | 0.64 (84%) |
| rs770734388 | P360S | Disease | 3 | 0.65 | Disease | 0 | 0.503 | Disease | 0.84 (90%) |
| rs754454928 | R441C | Disease | 5 | 0.743 | Disease | 5 | 0.775 | Disease | 0.61 (83%) |
| rs778432682 | R441H | Disease | 3 | 0.669 | Disease | 5 | 0.753 | Disease | 0.70 (86%) |
| rs1292596060 | R504S | Disease | 6 | 0.823 | Disease | 7 | 0.867 | Disease | 0.86 (91%) |
| rs759222387 | R504H | Disease | 6 | 0.811 | Disease | 7 | 0.857 | Disease | 0.72 (86%) |
[i] dbSNP rs*: is a locus accession for a variant type assigned by dbSNP, Sub*: substitution, RI*: Reliability Index
Table 3
stability analysis of 11 single nucleotides polymorphism using I-MUTANT showing decrease in the related protein stability. Variant effect on cancer was analyzed by COSMIC tool, which show the related type of mutations. Finally, the frequency alleles of the SNPs analyzed by dbSNP Short Genetic Variations that shows a frequency ranging from 0.0 to 0.00001.
| dbSNP rs# | sub | I-MUTANT prediction | SCORE | RI | COSMIC Mutation type | Frequency alleles |
|---|---|---|---|---|---|---|
| rs200806263 | G49C | Decrease | -0.91 | 5 | N/A | 0.00000 |
| rs1060500015 | L63P | Decrease | -1.61 | 2 | Deletion - Frameshift | N/A* |
| rs121434264 | L64P | Decrease | -1.58 | 2 | N/A | 0.0000 |
| rs778467088 | D90H | Decrease | -1.19 | 9 | N/A | 0.00001 |
| rs770439843 | R222G | Decrease | -1.23 | 6 | Substitution - Nonsense | 0.00001 |
| rs1060500022 | W231R | Decrease | -1.07 | 8 | Substitution - Nonsense | N/A |
| rs770734388 | P360S | Decrease | -1.45 | 8 | N/A | 0.00001 |
| rs754454928 | R441C | Decrease | -0.91 | 7 | Substitution - Missense | 0.00001 |
| rs778432682 | R441H | Decrease | -1.31 | 9 | N/A | 0.00001 |
| rs1292596060 | R504S | Decrease | -1.3 | 9 | N/A | N/A |
| rs759222387 | R504H | Decrease | -1.52 | 9 | N/A | 0.00004 |
[i] dbSNP rs*: is a locus accession for a variant type assigned by dbSNP, Sub*: substitution, RI*: Reliability Index, N/A: not available

Figure 1
Paper workflow, which shows the used methods and soft wares in the paper.
Table 4
CDC73 gene Functions and its appearance in network and genome as predicted by Gene mania. Showing the function, number of genes in network and in the genomes.
| Function | FDR | Genes in network | Genes in genome |
|---|---|---|---|
| transcription elongation factor complex | 2.52E-09 | 6 | 28 |
| regulation of transcription elongation from RNA polymerase II promoter | 2.52E-09 | 5 | 10 |
| transcription elongation from RNA polymerase II promoter | 6.60E-09 | 7 | 75 |
| DNA-templated transcription, elongation | 5.45E-08 | 7 | 108 |
| positive regulation of DNA-templated transcription, elongation | 5.45E-08 | 5 | 20 |
| mRNA polyadenylation | 7.21E-08 | 5 | 22 |
| RNA polyadenylation | 9.97E-08 | 5 | 24 |
| regulation of DNA-templated transcription, elongation | 2.01E-07 | 5 | 28 |
| histone modification | 3.31E-07 | 8 | 260 |
| covalent chromatin modification | 3.47E-07 | 8 | 265 |
| DNA-directed RNA polymerase II, holoenzyme | 3.50E-07 | 6 | 81 |
| endodermal cell fate commitment | 3.50E-07 | 4 | 10 |
| RNA polymerase complex | 7.92E-07 | 6 | 96 |
| DNA-directed RNA polymerase complex | 7.92E-07 | 6 | 95 |
| nuclear DNA-directed RNA polymerase complex | 7.92E-07 | 6 | 95 |
| endodermal cell differentiation | 8.50E-07 | 4 | 13 |
| negative regulation of myeloid cell differentiation | 1.03424E-06 | 5 | 44 |
| cell fate commitment involved in formation of primary germ layer | 2.50852E-06 | 4 | 17 |
| histone monoubiquitination | 3.86491E-06 | 4 | 19 |
| endoderm formation | 5.6616E-06 | 4 | 21 |
| mRNA processing | 1.22928E-05 | 7 | 287 |
| endoderm development | 1.28119E-05 | 4 | 26 |
| histone ubiquitination | 2.24022E-05 | 4 | 30 |
| mRNA 3’-end processing | 2.5645E-05 | 5 | 88 |
| regulation of myeloid cell differentiation | 4.02517E-05 | 5 | 97 |
| protein monoubiquitination | 4.41323E-05 | 4 | 37 |
| formation of primary germ layer | 4.41323E-05 | 4 | 37 |
| RNA 3’-end processing | 4.41323E-05 | 5 | 101 |
| regulation of mRNA processing | 0.000289177 | 4 | 59 |
| positive regulation of mRNA 3’-end processing | 0.000313172 | 3 | 15 |
| regulation of mRNA 3’-end processing | 0.000372752 | 3 | 16 |
| myeloid cell diferentiation | 0.000446549 | 5 | 165 |
| Gastrulation | 0.000451884 | 4 | 68 |
| positive regulation of mRNA processing | 0.000804394 | 3 | 21 |
| histone H3-K4 methylation | 0.001915467 | 3 | 28 |
| cell fate commitment | 0.002956445 | 4 | 111 |
| negative regulation of cell differentiation | 0.004090933 | 5 | 267 |
| stem cell maintenance | 0.005276884 | 3 | 40 |
| histone lysine methylation | 0.006873226 | 3 | 44 |
| regulation of histone modification | 0.011780086 | 3 | 53 |
| histone methylation | 0.01357129 | 3 | 56 |
| stem cell diferentiation | 0.013955822 | 4 | 171 |
| cellular response to lipopolysaccharide | 0.01758198 | 3 | 62 |
| regulation of chromatin organization | 0.018029071 | 3 | 63 |
| cellular response to molecule of bacterial origin | 0.020035617 | 3 | 66 |
| embryonic morphogenesis | 0.020035617 | 4 | 192 |
| RNA polymerase II core binding | 0.020433712 | 2 | 10 |
| peptidyl-lysine trimethylation | 0.022132906 | 2 | 11 |
| basal transcription machinery binding | 0.022132906 | 2 | 11 |
| basal RNA polymerase II transcription machinery binding | 0.022132906 | 2 | 11 |
| mRNA cleavage | 0.022132906 | 2 | 11 |
| transcriptionally active chromatin | 0.022132906 | 2 | 11 |
| regulation of histone H3-K4 methylation | 0.022132906 | 2 | 11 |
| protein alkylation | 0.022434688 | 3 | 73 |
| protein methylation | 0.022434688 | 3 | 73 |
| cellular response to biotic stimulus | 0.022949254 | 3 | 74 |
| mRNA cleavage factor complex | 0.024254179 | 2 | 12 |
| RNA polymerase core enzyme binding | 0.024254179 | 2 | 12 |
| positive regulation of histone methylation | 0.028159975 | 2 | 13 |
| response to lipopolysaccharide | 0.037153654 | 3 | 90 |
| stem cell development | 0.037153654 | 3 | 90 |
| regulation of chromosome organization | 0.037153654 | 3 | 90 |
| RNA polymerase binding | 0.040493707 | 2 | 16 |
| regulation of histone methylation | 0.04514658 | 2 | 17 |
| response to molecule of bacterial origin | 0.049891593 | 3 | 101 |
| peptidyl-lysine methylation | 0.054973868 | 2 | 19 |
| macromolecule methylation | 0.080506456 | 3 | 120 |
[i] *FDR: false discovery rate is greater than or equal to the probability that this is a false positive
Table 5
The gene co-expressed, share domain and interaction with CDC73 gene network, as predicted by Gene mania. Showing the type of interaction between different genes and CDC73 gene.
| Gene 1 | Gene 2 | Weight | Network group |
|---|---|---|---|
| AP3S1 | HSP90AA1 | 0.013259681 | Co-expression |
| CTR9 | CDC73 | 0.008208696 | Co-expression |
| CTR9 | LEO1 | 0.003100712 | Co-expression |
| WDR61 | LEO1 | 0.007506342 | Co-expression |
| WDR61 | CTR9 | 0.003934787 | Co-expression |
| KMT2C | BCL9L | 0.01605392 | Co-expression |
| CDK9 | CPSF4 | 0.007431932 | Co-expression |
| GTF2F1 | PAF1 | 0.004063675 | Co-expression |
| GTF2F1 | KMT2C | 0.008976047 | Co-expression |
| AURKB | TKT | 0.011608324 | Co-expression |
| NUP98 | CTR9 | 0.014227687 | Co-expression |
| CPSF4 | TKT | 0.00430011 | Co-expression |
| CPSF4 | AURKB | 0.006637127 | Co-expression |
| CHUK | CSTF3 | 0.016616315 | Co-expression |
| CSTF2 | AURKB | 0.004579851 | Co-expression |
| CHUK | CDC73 | 0.001583963 | Co-expression |
| CHUK | NUP98 | 0.004846978 | Co-expression |
| GTF2F1 | TKT | 0.009125041 | Co-expression |
| CPSF4 | CSTF3 | 0.014529244 | Co-expression |
| CHUK | NUP98 | 0.008912819 | Co-expression |
| NUP98 | CDC73 | 0.00588025 | Co-expression |
| CHUK | CDC73 | 0.001885684 | Co-expression |
| CSTF2 | LEO1 | 0.006971632 | Co-expression |
| CSTF3 | CTR9 | 0.006781118 | Co-expression |
| CHUK | CDC73 | 0.011535326 | Co-expression |
| CHUK | CTR9 | 0.00340099 | Co-expression |
| AP3S1 | CTR9 | 0.004597292 | Co-expression |
| GTF2F1 | PAF1 | 0.010657921 | Co-expression |
| GTF2F1 | CPSF4 | 0.011196721 | Co-expression |
| CSTF2 | CTR9 | 0.011377413 | Co-expression |
| CDK9 | CPSF4 | 0.009146069 | Co-expression |
| AURKB | CSTF3 | 0.006553773 | Co-expression |
| SPCS3 | CHUK | 0.00718225 | Co-expression |
| AURKB | NUP98 | 0.004425747 | Pathway |
| CPSF4 | CSTF3 | 0.11179613 | Pathway |
| CHUK | HSP90AA1 | 0.006348364 | Pathway |
| CSTF2 | CSTF3 | 0.009734826 | Pathway |
| CSTF2 | CPSF4 | 0.11179613 | Pathway |
| GTF2F1 | CSTF3 | 0.005905584 | Pathway |
| GTF2F1 | CSTF2 | 0.005905584 | Pathway |
| GTF2F1 | CDK9 | 0.011108032 | Pathway |
| CSTF2 | CSTF3 | 0.011789562 | Pathway |
| GTF2F1 | CSTF3 | 0.008021638 | Pathway |
| GTF2F1 | CSTF2 | 0.007878398 | Pathway |
| GTF2F1 | CDK9 | 0.014240757 | Pathway |
| CHUK | HSP90AA1 | 0.088913664 | Pathway |
| LEO1 | CDC73 | 0.122442566 | Physical Interactions |
| PAF1 | CDC73 | 0.21769759 | Physical Interactions |
| PAF1 | LEO1 | 0.15407903 | Physical Interactions |
| CTR9 | CDC73 | 0.21769759 | Physical Interactions |
| CTR9 | LEO1 | 0.15407903 | Physical Interactions |
| CTR9 | PAF1 | 0.27394587 | Physical Interactions |
| WDR61 | CDC73 | 0.21769759 | Physical Interactions |
| WDR61 | LEO1 | 0.15407903 | Physical Interactions |
| WDR61 | PAF1 | 0.27394587 | Physical Interactions |
| WDR61 | CTR9 | 0.27394587 | Physical Interactions |
| HSP90AA1 | CDC73 | 0.3958806 | Physical Interactions |
| CDK9 | HSP90AA1 | 0.20299108 | Physical Interactions |
| CDK9 | CDC73 | 0.119673245 | Physical Interactions |
| AURKB | CDC73 | 0.1827706 | Physical Interactions |
| AURKB | HSP90AA1 | 0.042777777 | Physical Interactions |
| PAF1 | CDC73 | 0.13507365 | Physical Interactions |
| CTR9 | CDC73 | 0.18643428 | Physical Interactions |
| NUP98 | CDC73 | 0.203537 | Physical Interactions |
| NUP98 | PAF1 | 0.31207067 | Physical Interactions |
| CHUK | CDC73 | 0.1774874 | Physical Interactions |
| CHUK | PAF1 | 0.2721304 | Physical Interactions |
| CDK9 | HSP90AA1 | 0.040214784 | Physical Interactions |
| LEO1 | CDC73 | 0.20954604 | Physical Interactions |
| PAF1 | CDC73 | 0.16041815 | Physical Interactions |
| PAF1 | LEO1 | 0.08672058 | Physical Interactions |
| CTR9 | CDC73 | 0.24223034 | Physical Interactions |
| CTR9 | LEO1 | 0.1309475 | Physical Interactions |
| CTR9 | PAF1 | 0.10024697 | Physical Interactions |
| CSTF2 | CSTF3 | 0.24596581 | Physical Interactions |
| GTF2F1 | CDC73 | 0.1822143 | Physical Interactions |
| GTF2F1 | CDK9 | 0.077137925 | Physical Interactions |
| LEO1 | CDC73 | 0.3225924 | Physical Interactions |
| PAF1 | CDC73 | 0.3225924 | Physical Interactions |
| CTR9 | CDC73 | 0.3225924 | Physical Interactions |
| WDR61 | CDC73 | 0.17647609 | Physical Interactions |
| CSTF3 | CDC73 | 0.3225924 | Physical Interactions |
| FIP1L1 | CDC73 | 0.3225924 | Physical Interactions |
| CPSF4 | CDC73 | 0.17647609 | Physical Interactions |
| CHUK | HSP90AA1 | 0.02887361 | Physical Interactions |
| KMT2C | CDC73 | 0.15483053 | Physical Interactions |
| CSTF2 | CDC73 | 0.16203262 | Physical Interactions |
| LEO1 | CDC73 | 0.09317254 | Physical Interactions |
| PAF1 | CDC73 | 0.08377836 | Physical Interactions |
| PAF1 | LEO1 | 0.07275753 | Physical Interactions |
| CTR9 | CDC73 | 0.09010142 | Physical Interactions |
| CTR9 | LEO1 | 0.078248814 | Physical Interactions |
| CTR9 | PAF1 | 0.07035932 | Physical Interactions |
| WDR61 | CDC73 | 0.114276804 | Physical Interactions |
| WDR61 | LEO1 | 0.09924398 | Physical Interactions |
| WDR61 | PAF1 | 0.089237645 | Physical Interactions |
| WDR61 | CTR9 | 0.09597274 | Physical Interactions |
| AP3S1 | CDC73 | 0.2352175 | Physical Interactions |
| CSTF2 | CSTF3 | 0.077111326 | Physical Interactions |
| LEO1 | CDC73 | 0.049589828 | Physical Interactions |
| PAF1 | CDC73 | 0.10079521 | Physical Interactions |
| PAF1 | LEO1 | 0.11382505 | Physical Interactions |
| CTR9 | CDC73 | 0.01533186 | Physical Interactions |
| CTR9 | LEO1 | 0.017313818 | Physical Interactions |
| CTR9 | PAF1 | 0.035191692 | Physical Interactions |
| WDR61 | CDC73 | 0.041940387 | Physical Interactions |
| WDR61 | LEO1 | 0.047362044 | Physical Interactions |
| WDR61 | PAF1 | 0.09626707 | Physical Interactions |
| WDR61 | CTR9 | 0.014643089 | Physical Interactions |
| FIP1L1 | CSTF3 | 0.113308094 | Physical Interactions |
| CPSF4 | FIP1L1 | 0.14965165 | Physical Interactions |
| CSTF2 | FIP1L1 | 0.10615889 | Physical Interactions |
| CDK9 | CTR9 | 0.0411037 | Physical Interactions |
| LEO1 | CDC73 | 0.05172406 | Physical Interactions |
| PAF1 | CDC73 | 0.028004196 | Physical Interactions |
| PAF1 | LEO1 | 0.054951686 | Physical Interactions |
| CTR9 | CDC73 | 0.04297603 | Physical Interactions |
| CTR9 | LEO1 | 0.08433042 | Physical Interactions |
| CTR9 | PAF1 | 0.045657773 | Physical Interactions |
| WDR61 | CDC73 | 0.04966663 | Physical Interactions |
| WDR61 | LEO1 | 0.09745915 | Physical Interactions |
| WDR61 | PAF1 | 0.05276587 | Physical Interactions |
| WDR61 | CTR9 | 0.080975994 | Physical Interactions |
| CSTF3 | CDC73 | 0.06669109 | Physical Interactions |
| FIP1L1 | CSTF3 | 0.14174445 | Physical Interactions |
| AURKB | HSP90AA1 | 0.002030884 | Physical Interactions |
| CPSF4 | CDC73 | 0.09574746 | Physical Interactions |
| CPSF4 | FIP1L1 | 0.20350051 | Physical Interactions |
| CHUK | HSP90AA1 | 0.001720827 | Physical Interactions |
| BCL9L | CDC73 | 0.2791709 | Physical Interactions |
| KMT2C | CDC73 | 0.04642578 | Physical Interactions |
| CSTF2 | CDC73 | 0.0463337 | Physical Interactions |
| CSTF2 | CSTF3 | 0.11722768 | Physical Interactions |
| CDK9 | PAF1 | 0.01438359 | Physical Interactions |
| GTF2F1 | CDK9 | 0.013446528 | Physical Interactions |
| AURKB | HSP90AA1 | 0.03819712 | Physical Interactions |
| CDK9 | HSP90AA1 | 0.03819712 | Physical Interactions |
| LEO1 | CDC73 | 0.5193767 | Physical Interactions |
| PAF1 | CDC73 | 0.5193767 | Physical Interactions |
| CTR9 | CDC73 | 0.37205398 | Physical Interactions |
| WDR61 | CDC73 | 0.5193767 | Physical Interactions |
| AURKB | HSP90AA1 | 0.080966905 | Physical Interactions |
| CDK9 | HSP90AA1 | 0.036444858 | Physical Interactions |
| LEO1 | CDC73 | 0.0771831 | Physical Interactions |
| PAF1 | CDC73 | 0.031383026 | Physical Interactions |
| PAF1 | LEO1 | 0.14005615 | Physical Interactions |
| CTR9 | CDC73 | 0.058806863 | Physical Interactions |
| CTR9 | PAF1 | 0.10671071 | Physical Interactions |
| WDR61 | CTR9 | 0.34459004 | Physical Interactions |
| CPSF4 | FIP1L1 | 0.44817418 | Physical Interactions |
| CHUK | HSP90AA1 | 0.0081622 | Physical Interactions |
| HSF2BP | CDC73 | 0.31519976 | Physical Interactions |
| CDK9 | HSP90AA1 | 0.010792454 | Physical Interactions |
| HSF2BP | CDC73 | 0.58701295 | Physical Interactions |
| CPSF4 | FIP1L1 | 0.6677753 | Physical Interactions |
| CHUK | HSP90AA1 | 0.007963367 | Physical Interactions |
| CSTF2 | CSTF3 | 0.2417784 | Physical Interactions |
| CTR9 | LEO1 | 0.09094542 | Predicted |
| CTR9 | LEO1 | 0.0869592 | Predicted |
| LEO1 | CDC73 | 1 | Predicted |
| CPSF4 | FIP1L1 | 1 | Predicted |
| CSTF3 | LEO1 | 0.020077549 | Predicted |
| FIP1L1 | CSTF3 | 0.015798066 | Predicted |
| NUP98 | CTR9 | 0.047920566 | Predicted |
| SPCS3 | CDC73 | 0.25866398 | Predicted |
| CTR9 | LEO1 | 0.34126943 | Predicted |
| TKT | CDC73 | 1 | Predicted |
| TKT | CDC73 | 1 | Predicted |
| CHUK | AURKB | 0.006874138 | Shared protein domains |
| CDK9 | AURKB | 0.003942981 | Shared protein domains |
| CDK9 | CHUK | 0.006889931 | Shared protein domains |
| CHUK | AURKB | 0.003882364 | Shared protein domains |
| CDK9 | AURKB | 0.002896895 | Shared protein domains |
| CDK9 | CHUK | 0.004389529 | Shared protein domains |

Figure 2
SNPs ID: rs200806263: G49C: The amino acid Glycine (green color) changed to Cysteine (red color) at position 49. Illustration was done by UCSF Chimera (v 1.10.2.) and project HOPE.

Figure 3
SNPs ID: rs1060500015: L63P: The amino acids Leucine (green color) changed to Proline (red color) at position 63. Illustration was done by UCSF Chimera (v 1.10.2.) and project HOPE.

Figure 4
SNPs ID: rs121434264: L64P: The amino acid Leucine (green color) changed to Proline (red color) at position 64. Illustration was done by UCSF Chimera (v 1.10.2.) and project HOPE.

Figure 5
SNPs ID: rs778467088: D90H: The amino acid Aspartic acid (green color) changed to Histidine (red color) at position 90. Illustration was done by UCSF Chimera (v 1.10.2.) and project HOPE.

Figure 6
SNPs ID: rs770439843: R222G: The amino acid Arginine (green color) changed to Glycine (red color) at position 222. Illustration was done by UCSF Chimera (v 1.10.2.) and project HOPE.

Figure 7
SNPs ID: rs1060500022: W231R: The amino acid Tryptophan (green color) changed to Arginine (red color) at position 231. Illustration was done by UCSF Chimera (v 1.10.2.) and project HOPE.

Figure 8
SNPs ID: rs770734388:P360S: The amino acid Proline (green color) changed to Serine (red color) at position 360. Illustration was done by UCSF Chimera (v 1.10.2.) and project HOPE.

Figure 9
SNPs ID: rs754454928: R441C: The amino acid Arginine (green color) changed to Cysteine ( red color) at position 441. Illustration was done by UCSF Chimera (v 1.10.2.) and project HOPE.

Figure 10
SNPs ID: rs778432682: R441H: The amino acid Arginine (green color) changed to Histidine (red color) at position 441. Illustration was done by UCSF Chimera (v 1.10.2.) and project HOPE.

Figure 11
SNPs ID: rs1292596060: R504S: The amino acid Arginine (green color) changed to Serine (red color) at position 504. Illustration was done by UCSF Chimera (v 1.10.2.) and project HOPE.

Figure 12
SNPs ID: rs759222387: R504H: The amino acid Arginine (green color) changed to Histidine (red color) at position 504. Illustration was done by UCSF Chimera (v 1.10.2.) and project HOPE.

Figure 13
Interaction between CDC73 gene and related genes using Gene MANIA software showing the different types of interactions between these genes. With physical interactions being the most significant type (76.64%).